— Featured Story
Let’s get on pancreatic cancer’s nerves
CSHL postdoc Jeremy Nigri and colleagues in the Tuveson lab have discovered that the nervous system plays a role in pancreatic cancer development.
Learn MoreCold Spring Harbor Laboratory, a 501(c)(3) non-profit, powers transformational discoveries in Cancer, Genomics, Neuroscience, Artificial Intelligence, Plant Biology & Quantitative Biology by educating and empowering scientific pioneers.
CSHL provides a powerful and productive environment to Discover, Develop, Connect & Share world-changing ideas that advance the field of bioscience — for more than 100 years, today and into the future.
CSHL pursues the biggest questions in science. We cultivate and nurture a constant flow of ideas by inspiring Curiosity, Discovery & Innovation.
Latest News From The LabAsking and answering big questions to advance knowledge
Learn About Our ResearchLearn more about our education programs sparking curiosity
Banbury Center
Convening thought leaders to shape tomorrow’s society
Center for Humanities
Capturing the legacy of science to inform modern biology
Cold Spring Harbor Laboratory Press
Disseminating scientific knowledge to advance research
DNA Learning Center
Fueling young minds and supporting great teachers
Meetings & Courses Program
Connecting scientists in a unique environment to explore new ideas
Ph.D. Program
Training the next generation of scientific pioneers and life-changers
Support CSHL’s mission to make life better
Donate TodayCSHL postdoc Jeremy Nigri and colleagues in the Tuveson lab have discovered that the nervous system plays a role in pancreatic cancer development.
Learn MoreCSHL Professor Nicholas Tonks and colleagues find that blocking the PTP1B enzyme may help the brain fight Alzheimer’s and protect memory.
Read StoryHear how early-stage ideas become new tools and therapies that can benefit patients, researchers, and other groups worldwide.
Listen NowThe aspiring physician-scientists have received awards from the American Society for Clinical Investigation and PhRMA Foundation.
Read Story